Wnt proteins, a group of secreted glycoproteins, mainly combine with receptors Frizzled (FZD) and/or low-density-lipoprotein receptor-related proteins 5/6 (LRP5/6), initiating β-catenin-dependent and -independent signaling pathways. These pathways, which can be regulated by some secreted antagonists such as secreted Frizzled-related proteins (SFRP) and dickkopf-related protein (DKK), play a critical role in embryo development and adult homeostasis. Overactivation of Wnt signaling has been implicated in some human diseases including cancer. Wnt transgenic mice provide convincing evidence that Wnt signaling is involved in breast cancer initiation and progression, which is further strengthened by observations on human clinical breast cancer patients and studies on in vitro cultured human breast cancer cells. This review focuses on the roles of Wnt ligands, receptors and antagonists in breast cancer development instead of molecules or signaling transactivating β-catenin independent on Wnt upstream components.
Wnt1 mice show apparent ductal hyperplasia, and some of them can develop breast cancer as early as 6 months of age; histological, MMTV-Wnt1 tumors show heterogeneous containing myoepithelial (basal-like) cells and luminal epithelial cells. 4 MMTV-Wnt10b mice and MMTV-LRP6 mice have a similar phenotype to MMTV-Wnt1 mice. 5, 6 Tumors from these mice show activation of the β-catenin pathway ( Figure 1 ). Consistently, active β-catenin transgenic (MMTV-βcatΔN) mice and MMTV-c-Myc mice also develop mammary hyperplasia and adenocarcinoma. 4 ,7
| WN T LIGANDS, RECEPTORS AND ANTAGONISTS ARE ABERRANTLY EXPRE SSED IN HUMAN BREAST CANCERS
Although Wnt1 transgenic mice prove the capacity of the Wnt/β-catenin pathway to initiate breast cancer, Wnt1 protein was hardly found overexpressed in human breast cancers. 8 In contrast, Wnt10b
is highly expressed in TNBC; Wnt10b activates the canonical β-catenin pathway and contributes to increased cell proliferation and renewal. 9 Wnt7b is expressed in several breast cancer cells and is overexpressed in approximately 10% of breast cancer patients. 10 Moreover, Wnt receptors LRP6 and FZD7 are also overexpressed.
LRP6 knockdown suppresses breast cancer cell growth, accompanied by a reduction in β-catenin signaling activity. 11 Similarly, FZD7 Protein C receptor is a single-pass transmembrane protein and is expressed in hematopoietic, neuronal and epithelial progenitor populations. 43 As a Wnt3a-target protein, it is also expressed in mouse Lgr5, functional roles of Procr in these cells remain unknown. 
| WN T SIGNALING IS OVERACTIVATED IN BASAL-LIKE BREAST CANCER/ TN BC

| WNT SIGNALING PLAYS A ROLE IN BRE AST CANCER METASTASIS-INITIATING CELLS
It has now been accepted now that metastasis is an early event in cancer progression. Using HER2 transgenic mice, studies have shown that breast cancer cells can disseminate in tumor premalignant stage, 71, 72 and EMT induced by both canonical and noncanonical Wnt signaling contributes to early dissemination. 73 These early disseminated cells show stem-like characteristics and have tumor-initiating capability. They are quiescent, but they can release from dormancy leading to distant metastasis. Therefore, they are also defined as MIC which may be responsible for tumor metastasis even years after removal of the primary tumors. Notably, one recent study showed that during dormancy, DKK1 suppresses Wnt signaling in MIC which was defined as latent competent cancer (LCC); downregulation of Wnt signaling induces LCC into quiescence to avoid immune surveillance. 74 Together, these findings raise a possibility 
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